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Microglia are often referred to as the immune cells of the brain. They are most definitely 
involved in immune responses to invading pathogens and inflammatory responses to 
tissue damage. However, recent results suggest microglia are vital for normal functioning 
of the brain. Neuroinflammation, as well as more subtle changes, in microglial function 
has been implicated in the pathogenesis of many brain diseases and disorders. Upon 
sensing alterations in their local environment, microglia change their shape and release 
factors that can modify the excitability of surrounding neurons. During neuroinflam-
mation, microglia proliferate and release NO, reactive oxygen species, cytokines and 
chemokines. If inflammation resolves then their numbers normalize again via apoptosis. 
Microglia express a wide array of ion channels and different types are implicated in all 
of the cellular processes listed above. Modulation of microglial ion channels has shown 
great promise as a therapeutic strategy in several brain disorders. In this review, we 
discuss recent advances in our knowledge of microglial ion channels and their roles in 
responses of microglia to changes in the extracellular milieu.
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Microglia express a variety of ion Channels
For cells that were, until relatively recently, thought to be quiescent in the normal brain and simply 
surveilling the surrounding tissue for damage or infection, microglia are exquisitely sensitive to their 
environment and express a remarkable array of different ion channels. In addition to many neuro-
transmitter sensitive and other ligand-gated ion channels, there is evidence for the presence of H+ 
channels, Na+ channels, voltage-gated Ca2+ channels, Ca2+-release-activated Ca2+ channels, voltage-
dependent and voltage-independent Cl− channels, and at least six different types of K+ channels in 
microglia (1). The later include inward rectifier, delayed rectifier, HERG-like, G-protein-activated, as 
well as voltage-dependent and voltage-independent Ca2+-activated K+ channels. Some of these chan-
nels are species specific, whereas others are commonly expressed between species, but the majority 
of these appear to be expressed in human microglia (1). For cells that not “excitable” in the neuronal 
sense, this large array of different channel types channels might seem superfluous, yet a substantial 
body of evidence suggests these channels regulate all of the important functions of microglia, 
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including activation, chemotaxis, secretion, proliferation, the 
respiratory burst (2, 3), and phagocytic activity (4). In addition, 
the expression level of most of these ion channels depends on 
the functional state of the microglial cell and several have been 
proposed as therapeutic targets in neurological diseases.
Ligand-Gated ion Channels Help Microglia 
to Monitor Their Local environment
Microglia express a variety of receptors that detect changes in 
their local environment, many of which are ligand-gated ion 
channels, including purinergic receptors, glutamate receptors, 
and other neurotransmitter gated channels (5–14). For example, 
microglial glutamate receptors include ionotropic receptors 
N-methyl-d-aspartic acid (NMDA), (S)-a-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA), and kainic acid 
(KA) receptors in addition to metabotropic glutamate receptors. 
Many of these receptors are sensitive to microglial secretions 
acting in an autocrine manner. For instance, neurotransmitters 
can induce microglial glutamate release, which can then act back 
on microglia to induce more neurotransmitter release. Microglia 
express receptors for ATP and cultured microglia release ATP 
following application of glutamate. This release is prevented by 
AMPA receptor blockers but not NMDA receptor inhibitors and 
is dependent on PKC activation and release of Ca2+ from stores, 
but not on extracellular Ca2+ (15). This type of autocrine action 
of microglial secretions has been reported by various in  vitro 
studies (8, 11, 15, 16) and it may provide positive feedback to 
allow rapid responses to danger signals and recruitment of sur-
rounding microglia in vivo. However, there is also evidence that 
microglia express only some of these receptors in their resting 
condition. Upon activation, they increase their expression of 
some receptors and begin to express others de novo. For instance, 
microglial P2X4 purinoreceptor expression is increased both by 
lipopolysaccharide (LPS) treatment in  vitro (17) and in spinal 
microglia following a peripheral nerve injury in vivo (5).
Among microglial receptors, P2X purinergic receptors have 
been extensively investigated due to their reported roles in micro-
glial activation in various pathological conditions linked to injury 
and inflammation (5, 18–20). As distinct from P2Y receptors 
that are G-protein coupled, P2X receptors are cation-permeable 
ligand-gated ion channels that open in response to the binding 
of extracellular purines, such as ATP, which are thought to be 
released from damaged/degenerating neuronal tissue. In micro-
glial cells, activation of these receptors results in entry of Ca2+, 
which subsequently causes various cellular responses associated 
with microglial function both in vitro and in vivo. For instance, 
several studies suggest a vital role for microglial P2X receptors 
(5, 21) in generating neuropathic pain following nerve injuries, 
although microglial P2Y receptors may also be involved (22, 
23). Some reports have suggested involvement of P2X receptors 
in microglial cytokine release and P2Y receptors in microglial 
chemotaxis (24). As with other immune cells, P2X7 receptors have 
been implicated not only in microglial inflammatory responses 
and inflammasome activation (25) but also in microglial prolif-
eration (26, 27). Genetic variants of P2X receptors are associated 
with neurodegenerative disease and appear to also play a role in 
microglial phagocytosis (28).
One of the most interesting consequences of microglial P2X 
receptor activation is the formation of membrane pores large 
enough to admit molecules, such as NMDG+ and DNA binding 
dyes. This process has been studied extensively for P2X7 receptors 
and may result in pro-inflammatory actions and cytolysis, but is 
also apparently required for the proliferative actions of P2X7 in 
microglia (26). A similar process was recently reported to occur 
following P2X4 receptor activation in microglial cells without 
consequent cell death (29). The formation of these pores may 
enable the release of factors that have paracrine and autocrine 
functions, such as glutamate (30), but will also pass Ca2+ and lead 
to a sustained increase in intracellular Ca2+, which in turn may 
underlie many of the downstream effects of P2X receptor activa-
tion on microglial function.
Role of increased intracellular Ca2+ in 
Microglial Function
Microglial responses, including morphological changes, migra-
tion, proliferation, and secretion of cytokines and reactive oxygen 
species, are usually associated with an increase in intracellular 
Ca2+ concentration ([Ca2+]i) (31, 32). The majority of receptor 
agonists known to cause microglial activation also cause an 
increase in [Ca2+]i, although often via different mechanisms and 
with markedly different consequences. For example, both ATP 
and LPS are capable of activating microglia in vitro and in vivo 
(33–37) and both cause an increase in [Ca2+]i. LPS does not 
produce an immediate Ca2+ response, but is reported to cause a 
sustained increase in basal [Ca2+]i in microglia after a 24-h treat-
ment (38), although this increase is evident as early as 1 h after 
LPS application (Figure  1). An intracellular Ca2+ chelator pre-
vented the LPS-stimulated increase in microglial NO, cytokines 
and chemokine release, but the Ca2+ ionophore ionomycin caused 
none of these effects. This suggests that elevated [Ca2+]i is neces-
sary but not sufficient for the pro-inflammatory actions of LPS on 
microglia (38). By contrast, ionomycin can mimic the stimulation 
of c-fos expression in microglia via glutamate receptor-mediated 
calcium influx (13).
Unlike LPS, Ca2+ imaging experiments show that ATP induces 
an immediate, transient increase in [Ca2+]i in microglia that is 
biphasic in many cells. The amplitude of this response is dose 
dependent and maximal at 300 μM. However, when ATP is applied 
in the absence of extracellular Ca2+, microglia commonly show no 
response or a smaller monophasic increase in [Ca2+]i (39). In the 
presence of extracellular Ca2+ and thapsigargin to block the endo-
plasmic reticulum calcium pump, microglia either responded to 
ATP or displayed an increased basal calcium (39), which has been 
shown to prevent ATP responses (38, 39). These results support 
the involvement of ionotropic receptors in the response to ATP, 
although metabotropic receptors and Ca2+ induced Ca2+ release 
may also be involved. These responses to ATP are not blocked 
by 100  μM suramin and similar [Ca2+]i increases are seen in 
response to the selective P2X receptor agonist 2-methylthio ATP, 
but not αβ-methylene ATP (40) suggesting P2X4 or P2X7 but not 
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P2X1 and P2X3 are involved (41, 42). Although the concentra-
tion dependence of the ATP-induced Ca2+ influx would suggest 
mediation by P2X4 receptors, the fact that similar responses 
are seen to the selective P2X7 receptor agonist 2′- and 3′-O- 
(4-benzoylbenzoyl) adenosine 5′-triphosphate (BzATP) indicates 
that functional P2X7 receptors are also present. Interestingly, 
pretreatment with oxidized ATP (oATP; 100 μM), which blocks 
P2X7 but not P2X4-mediated currents in microglia (43) pre-
vented the increase in [Ca2+]i induced by ATP concentrations 
(10 and 100 μM) that activate P2X4 but not P2X7 receptors (40). 
One possible explanation for this might be autocrine release of 
ATP (44), although other actions of oATP cannot be discounted.
FiGURe 1 | Sustained changes in intracellular Ca2+ concentration in 
microglia upon activation. When cultured neonatal rat microglia are 
stimulated with either ATP (A,B) or LPS (C), there is a sustained changed in 
intracellular Ca2+ levels as measured using Fura-2 ratiometric Ca2+ imaging 
that develops over 1 hour.
A later more sustained increase in [Ca2+]i similar to that 
reported following exposure to LPS can be seen in microglia fol-
lowing prolonged exposure to ATP at 30 μM or more (Figure 1). 
The time course and concentration dependence of this response 
are consistent with those of macropore formation in response to 
P2X4 activation measured via dye uptake (29). In contrast to LPS, 
however, application of 30–100 μM ATP does not cause release of 
cytokines, NO or activate a respiratory burst in microglia, again 
emphasizing that an increase in [Ca2+]i is not sufficient to stimu-
late these pro-inflammatory actions. Indeed, there is evidence 
that a prior sustained increase in [Ca2+]i can inhibit responses of 
microglia to further stimulation (38, 39). Changes in microglial 
morphology are seen when microglia are treated with 50–100 μM 
ATP (45); however, these changes are more subtle that those seen in 
response to LPS. The activation state induced in microglia by LPS 
is widely believed to be analogous to the M1 or pro-inflammatory 
activation state seen in macrophages. Whether or not the state 
induced by low micromolar concentrations of ATP in microglia is 
analogous to the M2, “alternate” or anti-inflammatory activation 
state of macrophages is less certain. It is clear, however, that P2X4 
receptors on microglia and their activation by ATP can contribute 
to neuronal hyperexcitability and pathological changes within the 
nervous system (5, 40). Higher concentrations of ATP that would 
activate P2X7 receptors are reported to cause pro-inflammatory 
actions, such as generation of a respiratory burst (46), but this is 
not the case in all studies, and may depend on the conditions of 
the experiment.
Other agents known to increase [Ca2+]i in microglia include 
glutamate (15), complement (38), interferon gamma and BDNF 
(47). BDNF release from microglia has been implicated in 
causing the increased excitability seen in dorsal horn neurons 
following peripheral nerve injury (48, 49). BDNF can also act 
back on microglial TrkB receptors to induce a sustained elevation 
of [Ca2+]i via a complex mechanism, but BDNF also suppresses 
IFN-γ-induced calcium influx and the associated increase in 
iNOS expression and nitric oxide release (47, 50). These results 
again illustrate that an increase in [Ca2+]i by itself is not enough 
to activate the overt inflammatory actions of microglia and may 
even inhibit them. They also emphasize that overt inflammatory 
responses are not required for microglia to participate in patho-
logical processes and nervous system disorders (Figure 2).
Role of voltage-Gated and Store-Operated 
Ca2+ Channels in Microglial Function
As discussed earlier, rat, mouse, and human microglia express a 
variety of Ca2+ channels, including voltage-gated Ca2+ channels 
and Ca2+-release-activated Ca2+ channels (1, 51). A study by 
Tokuhara et  al. demonstrated involvement of N-type calcium 
channels in monocyte chemoattractant protein-1 (MCP-1) pro-
duction from microglia. MCP-1 released from glial cells acts as a 
chemokine and attracts a variety of cells, including monocytes, T 
lymphocytes, and dendritic cells, to the brain (52). Store-operated 
Ca2+ entry (SOCE) has been demonstrated as another mechanism 
that supplies Ca2+ for intracellular processes in microglia via 
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Orai1/ICRAC channels (53). More recent evidence suggests that Ca2+ 
entry via SOCE plays an important role in responses to purines 
and BDNF and contributes to the activation of intracellular path-
ways causing cytokine secretion, phagocytosis, and chemotaxis 
(54, 55). In general, however, the role of these sources of Ca2+ in 
microglial signaling has not been investigated as thoroughly as 
have glutamate and purinergic receptors.
Microglial expression of K+ 
Channels – Kv1.3 and 1.5
In addition to the role of ligand-gated ion channels and cal-
cium influx, many studies have also demonstrated a critical 
role of K+ channels in various pro-inflammatory microglial 
functions. This is presumably because K+ channels prevent 
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FiGURe 2 | Schematic showing the various roles of ion channels in microglial function. Stimulation of microglia with either LPS or high concentrations of 
ATP (e.g., 3 mM) act via increased intracellular Ca2+ and intracellular signaling pathways such as MAP kinases and NF-κB. Low concentrations of ATP that stimulate 
P2X4 receptors (e.g., 100 μM), do not cause cytokine release or ROS production, but nevertheless do increase intracellular Ca2+ and produce morphological and 
functional changes that can lead to pathological changes in the function of surrounding neurons. Red arrows indicate potential autocrine and positive feedback 
mechanisms.
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depolarization of the membrane and maintain the driving force 
for Ca2+ entry as is proposed to occur in peripheral immune 
cells (56). The variety of these channels, however, and their 
roles in different aspects of microglial function have proven 
complex to unravel.
Initial reports suggested that, in culture, unstimulated 
microglia express only inward rectifying K+ channels (57), 
but that purine-, LPS-, gamma interferon-, or granulocyte 
macrophage colony stimulating factor-stimulated microglia 
display an outward K+ conductance (57–60). For instance, 
Norenberg et al. demonstrated a protein synthesis-dependent 
expression of outward K+ conductance peaking at 3  h after 
LPS exposure, which then gradually decreased despite the 
continued presence of LPS (57, 58). By contrast, Khanna et al. 
reported the presence both Kv1.5 and Kv1.3 channel protein in 
unstimulated microglial cell lysates, but saw only Kv1.3 like-
current as demonstrated by the complete blockade of the volt-
age-dependant current by agitoxin-2. Immunohistochemical 
analysis demonstrated that Kv1.3 was present on the microglial 
cell membrane, whereas Kv1.5 was found mainly intracellularly 
(2). Another in vitro study demonstrated a functional role for 
Kv1.5 in microglia (61). Unlike control/wildtype microglia, 
LPS-stimulated production of nitric oxide was not seen in 
microglia isolated from Kv1.5−/− knockout mice or microglia 
pre-treated with antisense oligonucleotide (AO) for Kv1.5, 
whereas LPS-stimulated chemokine release remained intact. By 
contrast, AO for Kv1.3 or pharmacological blockade of Kv1.3 
did not inhibit LPS-stimulated NO production, suggesting that 
KV1.5, but not Kv1.3 is required for the microglial NO release 
function (61, 62). Pannasch et al. also reported that decreasing 
expression of either Kv1.5 or Kv1.3 channels can prevent the 
LPS-mediated decrease in microglial proliferation. Moreover, 
increased microglial proliferation was observed in Kv1.5−/− 
mice after facial nerve injury in  vivo (61). Collectively, these 
studies suggest that inflammatory stimuli increase expression 
of microglial Kv 1.5 channels, which is required for increased 
NO production and inhibition of the cell cycle and but not 
chemokine release.
As mentioned above, Kv1.3 channels do appear to have a role 
in microglial proliferation (3), as well as cytokine release (63), 
morphological changes, and the NADPH oxidase-dependent 
respiratory burst response to PMA (2) as demonstrated by 
pharmacological blockade. Adhesion has also been suggested to 
regulate both microglia responses and expression of microglial 
K+ channels. Integrins are transmembrane glycoproteins respon-
sible for regulation of adhesion and the ability of immune cells 
to migrate. Microglia express several different integrin, including 
α4, α5, α6, β1, lymphocyte function-associated antigen-1, and 
Mac 1 β2-integrin. Interestingly, the pharmacological inhibition 
of Kv1.3 channels or of β-integrin also inhibits microglial migra-
tion toward various chemo attractants (64), although ATP was 
not tested. These results clearly indicate that Kv1.3 channels are 
also involved in microglial migration.
Fordyce et  al. also demonstrated that blockers of Kv1.3 
channels, but not Kv1.2, Kv1.5, and Kv1.6, inhibited the respira-
tory bust and consequent killing of neurons by microglia in 
co-culture (62), suggesting that Kv1.3 blockers may be useful 
as neuroprotective agents. With the development of potential 
therapeutic agents targeting this channel, their protective prop-
erties have been confirmed in a rat model of radiation-induced 
brain injury (65). The potential importance of these findings 
is emphasized by the recent demonstration of high levels of 
Kv1.3 in microglia in human brains from Alzheimer’s disease 
patients (66).
Other K+ Channels with Roles in Microglial 
Cytokines, nitric Oxide, and ROS 
Production
Some studies have also suggested a functional role for Kv1.1 and 
Kv1.2 shaker-like voltage-gated K+ channels in microglia. These 
channels are present in early postnatal microglia but disappear 
in ramified microglia present in adult rat brain. In vitro studies 
have reported induced expression (mRNA as well as protein) 
of Kv1.1 and Kv1.2 channels in microglia upon activation with 
LPS, hypoxia (67, 68), or ATP (68). Application of neutralizing 
antibodies to Kv1.1 is reported to reduce microglial cytokine 
(TNF-α, IL-1β) and nitric oxide production upon exposure 
to LPS or hypoxia (67). In contrast to Fordyce et  al., Li et  al. 
reported that an inhibitor of Kv1.2 channels reduced microglial 
cytokine mRNA production (TNF-α and IL1-β) and completely 
prevented ROS production in microglia and BV-2 cells exposed 
to LPS or hypoxia (68). Notably, none of the studies on Kv1.1 and 
Kv1.2 channels have reported complete inhibition of cytokine 
production suggesting the involvement of other pathways or ion 
channels.
Several studies have reported a functional role of Ca2+-
activated K+ channels in microglial function. For instance, the 
respiratory burst, but not the morphological changes in response 
to PMA were shown to be dependent on the Ca2+/calmodulin-
gated channels SK2, SK3, and SK4 (2). These investigators have 
now elaborated on this mechanism in a study published as part 
of this research topic (69).
Conclusion
In conclusion, microglial activation occurs via a cascade of 
extracellular and intracellular signaling events beginning with 
cell surface receptor and ligand-gated ion channel activation fol-
lowed by short-term and long-term changes in intracellular Ca2+. 
These Ca2+ signals can cause release of other factors in autocrine 
paracrine feedback loops and are necessary, although not suffi-
cient for various subsequent cellular responses in microglia. The 
roles of various K+ channels in enabling the different subsequent 
pro-inflammatory responses of microglia have been clearly 
demonstrated. Their role in more subtle microglial responses, 
in particular “alternate activation” and P2X-mediated events 
require more careful investigation. These more subtle events are 
potentially just as clinically relevant as the more overt inflamma-
tory functions of microglia and so a deeper understanding of the 
role of ion channels in these responses will no doubt have major 
consequences for human health.
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